Tag: FDA approval

Medications

Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents

Paragraph IV patent challenges let generic drug makers legally fight brand patents to bring cheaper medicines to market faster. Under the Hatch-Waxman Act, this system has saved U.S. consumers over $1.2 trillion since 1990.

Medications

Generic Drug Approval Standards: Safety, Quality, and Strength Requirements

Generic drugs must meet the same safety, quality, and strength standards as brand-name drugs under FDA regulations. Learn how bioequivalence testing, manufacturing rules, and complex product challenges shape approval.